Diabetes and impaired fasting glucose as predictors of morbidity and mortality in male coronary artery disease patients with reduced left ventricular function

Acta Cardiologica

Volumn 61, Issue 2, 2006, Pages 137-143

  Van De Veire, Nico R ^a,b   De Winter, Olivier ^a   Gillebert, Thierry C ^a   De Sutter, Johan ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Coronary artery disease; Diabetes mellitus; Heart failure; Impaired fasting glucose

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; BLOOD GLUCOSE; CORONARY ARTERIOSCLEROSIS; DEATH; DIABETES COMPLICATIONS; FASTING; GLUCOSE INTOLERANCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33645998721     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.2.2014326     Document Type: Article

References (13)

1. Schindler D, Kostis J, Yusuf S, Quinones M, Pitt B, Stewart D, Pinkett T, Ghali J, Wilson A for the SOLVD investigators. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol 1996; 77: 1017-20.
2. Dries D, Sweitzer N, Drazner M, Stevenson L, Gersh B. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001; 38: 421-8
3. de Groote P, Lamblin N, Mousquet F, Plichon D, McFadden E, Van Belle E, Bauters C. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 2004; 25: 656-62.
4. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
5. Fisman E, Motro M, Tenebaum A, Boylo V, Mandelzweig L, Behar S. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J 2001; 141: 485-90.
6. De Winter O, De Bondt P, Van De Wiele C, De Backer G, Dierckx RA, De Sutler J. Day-to-day variability of global left ventricular functional and perfusional measurements by quantitative gated SPECT using Tc-99 m tetrofosmin in patients with heart failure due to coronary artery disease. J Nucl Cardiol 2004; 11: 47-52.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
8. Ridker P, Buring J, Cook N, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391-7.
9. Sattar N, Gaw A, Scherbakova, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-9.
10. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
11. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994; 272: 1528-34.
12. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
13. Anderson JL, Horne BD, Jones HU, Reyna SP, Carlquist JF, Blair TL, Pearson RR, Lappe DL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease? Cardiology 2004; 101: 185-93.